Christopher Nolan's Oppenheimer returned to theaters and is set to overtake Zack Snyder's Batman v. Superman as it climbs toward $1 billion.
In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Day One Biopharmaceuticals (DAWN – Research Report), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback